PHIO PHARMACEUTICALS CORP (PHIO) Stock Balance Sheet
NASDAQ:PHIO - Nasdaq - US71880W5013 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.49M | 11.78M | 24.06M | 14.24M | 6.93M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 832.00K | 670.00K | 670.00K | 920.00K | 370.00K | |||
| Total Current Assets | 9.32M | 12.45M | 24.73M | 15.16M | 7.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 39.00K | 340.00K | 420.00K | 560.00K | 720.00K | |||
| Other Non-Current Assets | 3.00K | 20.00K | 30.00K | 20.00K | 20.00K | |||
| Total Non-Current Assets | 42.00K | 360.00K | 440.00K | 580.00K | 740.00K | |||
| TOTAL ASSETS | 9.36M | 12.81M | 25.17M | 15.74M | 8.04M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 977.00K | 1.16M | 2.79M | 1.47M | 1.07M | |||
| Accounts Payable | 657.00K | 780.00K | 280.00K | 730.00K | 810.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 1.63M | 1.94M | 3.07M | 2.20M | 1.88M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 230.00K | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 30.00K | 170.00K | 300.00K | 410.00K | |||
| Total Non-Current Liabilities | 0.00 | 30.00K | 170.00K | 520.00K | 410.00K | |||
| TOTAL LIABILITIES | 1.63M | 1.97M | 3.24M | 2.72M | 2.29M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -139.21M | -128.38M | -116.90M | -103.61M | -94.82M | |||
| Additional Paid In Capital | 146.94M | 139.22M | 138.83M | 116.63M | 100.57M | |||
| Common Shares | 400.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -400.00 | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 416.40K | 1.14M | 1.13M | 480.00K | 60.00K | |||
| Tangible Book Value per Share | 18.57 | 9.51 | 19.41 | 27.13 | 95.83 | |||
| Total Shareholders' Equity | 7.73M | 10.84M | 21.93M | 13.02M | 5.75M | |||
| TOTAL LIABILITIES AND EQUITY | 9.36M | 12.81M | 25.17M | 15.74M | 8.04M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.02 | N/A | |||
| Current Ratio | 5.71 | 6.42 | 8.06 | 6.89 | 3.88 | |||
| Return On Assets (ROA) | -115.61% | -89.62% | -52.80% | -55.84% | -110.82% | |||
| Return On Equity (ROE) | -140.05% | -105.90% | -60.60% | -67.51% | -154.96% | |||
All data in USD , ROIC based on taxRate of 0.21